Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

DOI Full Paper Access

293

Citations

27

References

2015

Year

Anish Thomas, Arun Rajan, Arlene Berman, Yusuke Tomita, Christina Brzezniak, Min-Jung Lee, Sunmin Lee, Alexander Ling, Aaron John Spittler, Corey A. Carter,

The Lancet Oncology

Open-label Phase 2OncologyClinical TrialsImmune Checkpoint InhibitorDermatologyCancer TreatmentThymic CarcinomaMedicineChemotherapy-refractory Thymoma

References

	Year	Citations

Page 1

Page 1